NFE2L2 and atrial fibrillation: Yehet al. [62] determined that statin administration was sufficient toreduce AF episodes through the promotion of NRF2/HO-1 upregulation withincardiomyocytes while protecting against oxidative stress tachycardia-inducedfibrillation, ultimately suppressing myocardial remodeling.